SEC Form 4 · accession 0001683168-17-001457
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay E Birnbaum
Director
Period of report
May 30, 2017
Accepted (ET)
Jun 1, 2017 · 8:30 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per shareF1 | May 30, 2017 | A | 612 | — | A | 9,161 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan.